Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response

Acromegaly is caused by excess growth hormone (GH) produced by a pituitary tumor. First-generation somatostatin receptor ligands (SRLs) are the first-line treatment. Several studies have linked E-cadherin loss and epithelial-mesenchymal transition (EMT) with resistance to SRLs. Our aim was to study...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Joan Gil, Montserrat Marques-Pamies, Elena Valassi, Araceli García-Martínez, Guillermo Serra, Cristina Hostalot, Carmen Fajardo-Montañana, Cristina Carrato, Ignacio Bernabeu, Mónica Marazuela, Helena Rodríguez-Lloveras, Rosa Cámara, Isabel Salinas, Cristina Lamas, Betina Biagetti, Andreu Simó-Servat, Susan M. Webb, Antonio Picó, Mireia Jordà, Manel Puig-Domingo
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-02-01
Sarja:	Biomedicines
Aiheet:	epithelial-mesenchymal transition acromegaly somatostatin receptor ligands (SRLs) somatostatin analogs (SSAs) RORC SNAI1
Linkit:	https://www.mdpi.com/2227-9059/10/2/460
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!